{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:56:51Z","timestamp":1793332611227,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12035-020-01921-6","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T05:03:42Z","timestamp":1589951022000},"page":"2920-2933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration"],"prefix":"10.1007","volume":"57","author":[{"given":"Kevin M.","family":"Budge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-6936","authenticated-orcid":false,"given":"Fayez F.","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"issue":"9996","key":"1921_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912","journal-title":"Lancet"},{"issue":"3","key":"1921_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A (2013) The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 28(3):311\u2013318","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"1921_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K et al (2011) Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1\u2013S58","journal-title":"Eur J Epidemiol"},{"issue":"Suppl 1","key":"1921_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson\u2019s disease. J Neurochem 139(Suppl 1):318\u2013324","journal-title":"J Neurochem"},{"key":"1921_CR5","first-page":"91","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J et al (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"issue":"9942","key":"1921_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","volume":"384","author":"AH Schapira","year":"2014","unstructured":"Schapira AH et al (2014) Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: future therapeutic perspectives. Lancet 384(9942):545\u2013555","journal-title":"Lancet"},{"key":"1921_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12916-015-0534-x","volume":"13","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD, Hassin-Baer S (2015) Can the disease course in Parkinson\u2019s disease be slowed? BMC Med 13:295","journal-title":"BMC Med"},{"issue":"Suppl 1","key":"1921_CR8","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S210\u2013S212","journal-title":"Parkinsonism Relat Disord"},{"key":"1921_CR9","doi-asserted-by":"crossref","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119(6):866\u2013872","DOI":"10.1289\/ehp.1002839"},{"key":"1921_CR10","doi-asserted-by":"publisher","first-page":"4784268","DOI":"10.1155\/2018\/4784268","volume":"2018","author":"G Gelders","year":"2018","unstructured":"Gelders G, Baekelandt V, Van der Perren A (2018) Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease. J Immunol Res 2018:4784268","journal-title":"J Immunol Res"},{"issue":"4","key":"1921_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397","journal-title":"Lancet Neurol"},{"key":"1921_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1921_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12011","volume":"39","author":"D Boche","year":"2013","unstructured":"Boche D, Perry VH, Nicoll JA (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39(1):3\u201318","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1921_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","volume":"9","author":"SR Subramaniam","year":"2017","unstructured":"Subramaniam SR, Federoff HJ (2017) Targeting microglial activation states as a therapeutic avenue in Parkinson\u2019s disease. Front Aging Neurosci 9:176","journal-title":"Front Aging Neurosci"},{"key":"1921_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8:1005","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"1921_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","volume":"690","author":"S Fuller","year":"2010","unstructured":"Fuller S, Steele M, Munch G (2010) Activated astroglia during chronic inflammation in Alzheimer\u2019s disease--do they neglect their neurosupportive roles? Mutat Res 690(1\u20132):40\u201349","journal-title":"Mutat Res"},{"key":"1921_CR17","doi-asserted-by":"crossref","unstructured":"Moller T (2010) Neuroinflammation in Huntington\u2019s disease. J Neural Transm (Vienna) 117(8):1001\u20131008","DOI":"10.1007\/s00702-010-0430-7"},{"key":"1921_CR18","doi-asserted-by":"crossref","unstructured":"Ellwardt E, Zipp F (2014) Molecular mechanisms linking neuroinflammation and neurodegeneration in MS. Exp Neurol (262 Pt A):8\u201317","DOI":"10.1016\/j.expneurol.2014.02.006"},{"issue":"8","key":"1921_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150(8):963\u2013976","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1921_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","volume":"72","author":"S Hunot","year":"1996","unstructured":"Hunot S, Boissi\u00e8re F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease. Neuroscience 72(2):355\u2013363","journal-title":"Neuroscience"},{"issue":"1","key":"1921_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","volume":"414","author":"M Mogi","year":"2007","unstructured":"Mogi M, Kondo T, Mizuno Y, Nagatsu T (2007) p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett 414(1):94\u201397","journal-title":"Neurosci Lett"},{"issue":"9","key":"1921_CR22","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","volume":"19","author":"S Hunot","year":"1999","unstructured":"Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debr\u00e9 P, Agid Y, Dugas B et al (1999) FcepsilonRII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19(9):3440\u20133447","journal-title":"J Neurosci"},{"issue":"2","key":"1921_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180(2):147\u2013150","journal-title":"Neurosci Lett"},{"issue":"2","key":"1921_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/neur.1996.0020","volume":"5","author":"A Czlonkowska","year":"1996","unstructured":"Czlonkowska A et al (1996) Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson\u2019s disease mice model. Neurodegeneration 5(2):137\u2013143","journal-title":"Neurodegeneration"},{"issue":"11","key":"1921_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","volume":"16","author":"K Sriram","year":"2002","unstructured":"Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O\u2019Callaghan JP (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease. FASEB J 16(11):1474\u20131476","journal-title":"FASEB J"},{"issue":"1","key":"1921_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V (2005) The MPTP model of Parkinson\u2019s disease. Brain Res Mol Brain Res 134(1):57\u201366","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"1921_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","volume":"25","author":"MG Purisai","year":"2007","unstructured":"Purisai MG, McCormack AL, Cumine S, Li J, Isla MZ, di Monte DA (2007) Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 25(2):392\u2013400","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1921_CR28","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.freeradbiomed.2012.02.005","volume":"52","author":"G Srivastava","year":"2012","unstructured":"Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP (2012) Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med 52(8):1294\u20131306","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"1921_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneuroim.2012.03.010","volume":"246","author":"M Sadeghian","year":"2012","unstructured":"Sadeghian M, Marinova-Mutafchieva L, Broom L, Davis JB, Virley D, Medhurst AD, Dexter DT (2012) Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression. J Neuroimmunol 246(1\u20132):69\u201377","journal-title":"J Neuroimmunol"},{"issue":"4","key":"1921_CR30","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jnutbio.2012.03.018","volume":"24","author":"P Shrivastava","year":"2013","unstructured":"Shrivastava P, Vaibhav K, Tabassum R, Khan A, Ishrat T, Khan MM, Ahmad A, Islam F et al (2013) Anti-apoptotic and anti-inflammatory effect of piperine on 6-OHDA induced Parkinson\u2019s rat model. J Nutr Biochem 24(4):680\u2013687","journal-title":"J Nutr Biochem"},{"issue":"11","key":"1921_CR31","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1177\/1535370215576313","volume":"240","author":"I Stojkovska","year":"2015","unstructured":"Stojkovska I, Wagner BM, Morrison BE (2015) Parkinson\u2019s disease and enhanced inflammatory response. Exp Biol Med (Maywood) 240(11):1387\u20131395","journal-title":"Exp Biol Med (Maywood)"},{"issue":"37","key":"1921_CR32","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","volume":"26","author":"MK McCoy","year":"2006","unstructured":"McCoy MK et al (2006) Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease. J Neurosci 26(37):9365\u20139375","journal-title":"J Neurosci"},{"key":"1921_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","volume":"269","author":"C Anusha","year":"2017","unstructured":"Anusha C, Sumathi T, Joseph LD (2017) Protective role of apigenin on rotenone induced rat model of Parkinson\u2019s disease: suppression of neuroinflammation and oxidative stress mediated apoptosis. Chem Biol Interact 269:67\u201379","journal-title":"Chem Biol Interact"},{"key":"1921_CR34","first-page":"327089","volume":"2011","author":"M Liu","year":"2011","unstructured":"Liu M, Bing G (2011) Lipopolysaccharide animal models for Parkinson\u2019s disease. Parkinsons Dis 2011:327089","journal-title":"Parkinsons Dis"},{"key":"1921_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2017.08.009","volume":"108","author":"EE Beier","year":"2017","unstructured":"Beier EE, Neal M, Alam G, Edler M, Wu LJ, Richardson JR (2017) Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis 108:115\u2013127","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1921_CR36","doi-asserted-by":"publisher","first-page":"9251","DOI":"10.1007\/s12035-018-1064-2","volume":"55","author":"M Cordaro","year":"2018","unstructured":"Cordaro M, Siracusa R, Crupi R, Impellizzeri D, Peritore AF, D\u2019Amico R, Gugliandolo E, di Paola R et al (2018) 2-Pentadecyl-2-oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson disease. Mol Neurobiol 55(12):9251\u20139266","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1921_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12974-017-1036-x","volume":"14","author":"Z Fan","year":"2017","unstructured":"Fan Z, Liang Z, Yang H, Pan Y, Zheng Y, Wang X (2017) Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia. J Neuroinflammation 14(1):256","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1921_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2004.01.010","volume":"16","author":"M Tomas-Camardiel","year":"2004","unstructured":"Tomas-Camardiel M et al (2004) Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16(1):190\u2013201","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1921_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","volume":"26","author":"HJ Park","year":"2007","unstructured":"Park HJ, Lee PH, Ahn YW, Choi YJ, Lee G, Lee DY, Chung ES, Jin BK (2007) Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neurosci 26(1):79\u201389","journal-title":"Eur J Neurosci"},{"issue":"5","key":"1921_CR40","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","volume":"100","author":"RL Hunter","year":"2007","unstructured":"Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG et al (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100(5):1375\u20131386","journal-title":"J Neurochem"},{"issue":"1","key":"1921_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ijc.2910600111","volume":"60","author":"MA Weterman","year":"1995","unstructured":"Weterman MA et al (1995) nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 60(1):73\u201381","journal-title":"Int J Cancer"},{"issue":"1","key":"1921_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jcp.25020","volume":"231","author":"N Frara","year":"2016","unstructured":"Frara N, Abdelmagid SM, Sondag GR, Moussa FM, Yingling VR, Owen TA, Popoff SN, Barbe MF et al (2016) Transgenic expression of osteoactivin\/gpnmb enhances bone formation in vivo and osteoprogenitor differentiation ex vivo. J Cell Physiol 231(1):72\u201383","journal-title":"J Cell Physiol"},{"key":"1921_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.08.013","volume":"120","author":"EB Moloney","year":"2018","unstructured":"Moloney EB, Moskites A, Ferrari EJ, Isacson O, Hallett PJ (2018) The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson\u2019s disease patients and increases after lysosomal stress. Neurobiol Dis 120:1\u201311","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1921_CR44","first-page":"4767","volume":"24","author":"B Li","year":"2010","unstructured":"Li B et al (2010) The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J 24(12):4767\u20134781","journal-title":"FASEB J"},{"key":"1921_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cellimm.2017.03.006","volume":"316","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zhuo H, Ouyang H, Liu Y, Yuan F, Sun L, Liu F, Liu H (2017) Glycoprotein non-metastatic melanoma protein b (Gpnmb) is highly expressed in macrophages of acute injured kidney and promotes M2 macrophages polarization. Cell Immunol 316:53\u201360","journal-title":"Cell Immunol"},{"issue":"11","key":"1921_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143413","volume":"10","author":"K Kumagai","year":"2015","unstructured":"Kumagai K, Tabu K, Sasaki F, Takami Y, Morinaga Y, Mawatari S, Hashimoto S, Tanoue S et al (2015) Glycoprotein nonmetastatic melanoma B (Gpnmb)-positive macrophages contribute to the balance between fibrosis and fibrolysis during the repair of acute liver injury in mice. PLoS One 10(11):e0143413","journal-title":"PLoS One"},{"issue":"2","key":"1921_CR47","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1096\/fj.201600613R","volume":"31","author":"A Jarve","year":"2017","unstructured":"Jarve A et al (2017) Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction. FASEB J 31(2):556\u2013568","journal-title":"FASEB J"},{"issue":"11","key":"1921_CR48","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1534\/g3.118.200655","volume":"8","author":"LY Lin","year":"2018","unstructured":"Lin LY et al (2018) Systems genetics approach to biomarker discovery: GPNMB and heart failure in mice and humans. G3 (Bethesda) 8(11):3499\u20133506","journal-title":"G3 (Bethesda)"},{"issue":"2","key":"1921_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1165\/rcmb.2013-0021OC","volume":"52","author":"T Narasaraju","year":"2015","unstructured":"Narasaraju T, Shukla D, More S, Huang C, Zhang L, Xiao X, Liu L (2015) Role of microRNA-150 and glycoprotein nonmetastatic melanoma protein B in angiogenesis during hyperoxia-induced neonatal lung injury. Am J Respir Cell Mol Biol 52(2):253\u2013261","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"1921_CR50","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/jnr.23619","volume":"93","author":"Y Nagahara","year":"2015","unstructured":"Nagahara Y, Shimazawa M, Tanaka H, Ono Y, Noda Y, Ohuchi K, Tsuruma K, Katsuno M et al (2015) Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neurosci Res 93(10):1552\u20131566","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"1921_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2016.11.034","volume":"481","author":"Y Ono","year":"2016","unstructured":"Ono Y, Chiba S, Yano H, Nakayama N, Saio M, Tsuruma K, Shimazawa M, Iwama T et al (2016) Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na(+)\/K(+)-ATPase. Biochem Biophys Res Commun 481(1\u20132):7\u201312","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1921_CR52","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/jnr.23999","volume":"95","author":"Y Nagahara","year":"2017","unstructured":"Nagahara Y, Shimazawa M, Ohuchi K, Ito J, Takahashi H, Tsuruma K, Kakita A, Hara H (2017) GPNMB ameliorates mutant TDP-43-induced motor neuron cell death. J Neurosci Res 95(8):1647\u20131665","journal-title":"J Neurosci Res"},{"key":"1921_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuroscience.2014.06.065","volume":"277","author":"Y Nakano","year":"2014","unstructured":"Nakano Y, Suzuki Y, Takagi T, Kitashoji A, Ono Y, Tsuruma K, Yoshimura S, Shimazawa M et al (2014) Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia-reperfusion injury. Neuroscience 277:123\u2013131","journal-title":"Neuroscience"},{"issue":"10","key":"1921_CR54","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.4049\/jimmunol.178.10.6557","volume":"178","author":"VM Ripoll","year":"2007","unstructured":"Ripoll VM, Irvine KM, Ravasi T, Sweet MJ, Hume DA (2007) Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol 178(10):6557\u20136566","journal-title":"J Immunol"},{"issue":"1","key":"1921_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12974-018-1100-1","volume":"15","author":"ML Neal","year":"2018","unstructured":"Neal ML, Boyle AM, Budge KM, Safadi FF, Richardson JR (2018) The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. J Neuroinflammation 15(1):73","journal-title":"J Neuroinflammation"},{"key":"1921_CR56","doi-asserted-by":"crossref","unstructured":"Plagnol V et al (2011) A two-stage meta-analysis identifies several new loci for Parkinson\u2019s disease. PLoS Genet:7(6)","DOI":"10.1371\/journal.pgen.1002142"},{"issue":"6","key":"1921_CR57","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.neurobiolaging.2012.10.019","volume":"34","author":"L Pihlstrom","year":"2013","unstructured":"Pihlstrom L et al (2013) Supportive evidence for 11 loci from genome-wide association studies in Parkinson\u2019s disease. Neurobiol Aging 34(6):1708 e7\u201313","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1921_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10048-017-0514-8","volume":"18","author":"MN Murthy","year":"2017","unstructured":"Murthy MN et al (2017) Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson\u2019s disease on chromosome 7p15.3. Neurogenetics 18(3):121\u2013133","journal-title":"Neurogenetics"},{"issue":"R1","key":"1921_CR59","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1093\/hmg\/ddv236","volume":"24","author":"R Kumaran","year":"2015","unstructured":"Kumaran R, Cookson MR (2015) Pathways to parkinsonism redux: convergent pathobiological mechanisms in genetics of Parkinson\u2019s disease. Hum Mol Genet 24(R1):R32\u2013R44","journal-title":"Hum Mol Genet"},{"key":"1921_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neulet.2016.04.060","volume":"622","author":"Y Xu","year":"2016","unstructured":"Xu Y, Chen YP, Ou RW, Wei QQ, Cao B, Chen K, Shang HF (2016) No association of GPNMB rs156429 polymorphism with Parkinson\u2019s disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population. Neurosci Lett 622:113\u2013117","journal-title":"Neurosci Lett"},{"key":"1921_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neurobiolaging.2017.11.016","volume":"64","author":"HC Wu","year":"2018","unstructured":"Wu HC et al (2018) DLG2, but not TMEM229B, GPNMB, and ITGA8 polymorphism, is associated with Parkinson\u2019s disease in a Taiwanese population. Neurobiol Aging 64:158 e1\u2013158 e6","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1921_CR62","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang D et al (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat Genet 49(10):1511\u20131516","journal-title":"Nat Genet"},{"issue":"1","key":"1921_CR63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2(1):141\u2013151","journal-title":"Nat Protoc"},{"issue":"5","key":"1921_CR64","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.neuro.2008.05.007","volume":"29","author":"JR Richardson","year":"2008","unstructured":"Richardson JR, Caudle WM, Wang MZ, Dean ED, Pennell KD, Miller GW (2008) Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in a gender-specific manner. Neurotoxicology 29(5):855\u2013863","journal-title":"Neurotoxicology"},{"issue":"1","key":"1921_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00216-009-2929-z","volume":"395","author":"B Winnik","year":"2009","unstructured":"Winnik B, Barr DB, Thiruchelvam M, Montesano MA, Richfield EK, Buckley B (2009) Quantification of Paraquat, MPTP, and MPP+ in brain tissue using microwave-assisted solvent extraction (MASE) and high-performance liquid chromatography-mass spectrometry. Anal Bioanal Chem 395(1):195\u2013201","journal-title":"Anal Bioanal Chem"},{"key":"1921_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuro.2017.03.008","volume":"60","author":"G Alam","year":"2017","unstructured":"Alam G, Edler M, Burchfield S, Richardson JR (2017) Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss. Neurotoxicology 60:99\u2013106","journal-title":"Neurotoxicology"},{"issue":"10","key":"1921_CR67","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/glia.23467","volume":"66","author":"M Neal","year":"2018","unstructured":"Neal M, Luo J, Harischandra DS, Gordon R, Sarkar S, Jin H, Anantharam V, D\u00e9saubry L et al (2018) Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes. Glia 66(10):2137\u20132157","journal-title":"Glia"},{"key":"1921_CR68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-2094-10-4","volume":"10","author":"HW Morrison","year":"2013","unstructured":"Morrison HW, Filosa JA (2013) A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J Neuroinflammation 10:4","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1921_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","volume":"39","author":"M Kohutnicka","year":"1998","unstructured":"Kohutnicka M, Lewandowska E, Kurkowska-Jastrz\u0119bska I, Cz\u0142onkowski A, Cz\u0142onkowska A (1998) Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39(3):167\u2013180","journal-title":"Immunopharmacology"},{"issue":"3","key":"1921_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.159","volume":"49","author":"YC Chung","year":"2017","unstructured":"Chung YC, Baek JY, Kim SR, Ko HW, Bok E, Shin WH, Won SY, Jin BK (2017) Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease. Exp Mol Med 49(3):e298","journal-title":"Exp Mol Med"},{"issue":"5","key":"1921_CR71","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H et al (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22(5):1763\u20131771","journal-title":"J Neurosci"},{"issue":"7","key":"1921_CR72","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/jcb.25394","volume":"117","author":"B Yu","year":"2016","unstructured":"Yu B, Sondag GR, Malcuit C, Kim MH, Safadi FF (2016) Macrophage-associated Osteoactivin\/GPNMB mediates mesenchymal stem cell survival, proliferation, and migration via a CD44-dependent mechanism. J Cell Biochem 117(7):1511\u20131521","journal-title":"J Cell Biochem"},{"issue":"5","key":"1921_CR73","doi-asserted-by":"publisher","first-page":"e0127768","DOI":"10.1371\/journal.pone.0127768","volume":"10","author":"NM Kanaan","year":"2015","unstructured":"Kanaan NM, Collier TJ, Cole-Strauss A, Grabinski T, Mattingly ZR, Winn ME, Steece-Collier K, Sortwell CE et al (2015) The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes. PLoS One 10(5):e0127768","journal-title":"PLoS One"},{"issue":"1","key":"1921_CR74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M Huttenrauch","year":"2018","unstructured":"Huttenrauch M et al (2018) Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun 6(1):108","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"1921_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120194","volume":"10","author":"H Zigdon","year":"2015","unstructured":"Zigdon H, Savidor A, Levin Y, Meshcheriakova A, Schiffmann R, Futerman AH (2015) Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease. PLoS One 10(3):e0120194","journal-title":"PLoS One"},{"issue":"8","key":"1921_CR76","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291","journal-title":"Neurology"},{"key":"1921_CR77","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"1921_CR78","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38(4):333\u2013347","journal-title":"Exp Mol Med"},{"key":"1921_CR79","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fncel.2018.00282","volume":"12","author":"C Lecours","year":"2018","unstructured":"Lecours C, Bordeleau M, Cantin L, Parent M, Paolo TD, Tremblay M\u00c8 (2018) Microglial implication in Parkinson\u2019s disease: loss of beneficial physiological roles or gain of inflammatory functions? Front Cell Neurosci 12:282","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1921_CR80","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/ejn.12231","volume":"38","author":"S Ailane","year":"2013","unstructured":"Ailane S, Long P, Jenner P, Rose S (2013) Expression of integrin and CD44 receptors recognising osteopontin in the normal and LPS-lesioned rat substantia nigra. Eur J Neurosci 38(3):2468\u20132476","journal-title":"Eur J Neurosci"},{"issue":"7","key":"1921_CR81","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/jcb.24760","volume":"115","author":"FM Moussa","year":"2014","unstructured":"Moussa FM, Hisijara IA, Sondag GR, Scott EM, Frara N, Abdelmagid SM, Safadi FF (2014) Osteoactivin promotes osteoblast adhesion through HSPG and alphavbeta1 integrin. J Cell Biochem 115(7):1243\u20131253","journal-title":"J Cell Biochem"},{"issue":"10","key":"1921_CR82","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/jcb.25175","volume":"116","author":"T Miyazaki","year":"2015","unstructured":"Miyazaki T, Miyauchi S, Anada T, Tawada A, Suzuki O (2015) Chondroitin sulfate-E binds to both osteoactivin and integrin alphaVbeta3 and inhibits osteoclast differentiation. J Cell Biochem 116(10):2247\u20132257","journal-title":"J Cell Biochem"},{"issue":"43","key":"1921_CR83","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1038\/onc.2015.8","volume":"34","author":"G Maric","year":"2015","unstructured":"Maric G, Annis MG, Dong Z, Rose AAN, Ng S, Perkins D, MacDonald PA, Ouellet V et al (2015) GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin alpha5beta1 for efficient breast cancer metastasis. Oncogene 34(43):5494\u20135504","journal-title":"Oncogene"},{"issue":"12","key":"1921_CR84","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/jcb.24621","volume":"114","author":"X Hu","year":"2013","unstructured":"Hu X, Zhang P, Xu Z, Chen H, Xie X (2013) GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: potential role for tissue engineering bone. J Cell Biochem 114(12):2729\u20132737","journal-title":"J Cell Biochem"},{"issue":"12","key":"1921_CR85","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1271\/bbb.120515","volume":"76","author":"K Utsunomiya","year":"2012","unstructured":"Utsunomiya K et al (2012) An intracellular fragment of osteoactivin formed by ectodomain shedding translocated to the nucleoplasm and bound to RNA binding proteins. Biosci Biotechnol Biochem 76(12):2225\u20132229","journal-title":"Biosci Biotechnol Biochem"},{"issue":"10","key":"1921_CR86","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1182\/blood-2006-11-053769","volume":"109","author":"JS Chung","year":"2007","unstructured":"Chung JS, Sato K, Dougherty II, Cruz PD Jr, Ariizumi K (2007) DC-HIL is a negative regulator of T lymphocyte activation. Blood 109(10):4320\u20134327","journal-title":"Blood"},{"issue":"1","key":"1921_CR87","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192","journal-title":"J Clin Invest"},{"issue":"1","key":"1921_CR88","doi-asserted-by":"publisher","first-page":"e0147208","DOI":"10.1371\/journal.pone.0147208","volume":"11","author":"AR Marques","year":"2016","unstructured":"Marques AR et al (2016) Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease. PLoS One 11(1):e0147208","journal-title":"PLoS One"},{"issue":"9","key":"1921_CR89","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/2211-5463.12078","volume":"6","author":"G Kramer","year":"2016","unstructured":"Kramer G, Wegdam W, Donker-Koopman W, Ottenhoff R, Gaspar P, Verhoek M, Nelson J, Gabriel T et al (2016) Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models. FEBS Open Bio 6(9):902\u2013913","journal-title":"FEBS Open Bio"},{"key":"1921_CR90","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fnagi.2018.00378","volume":"10","author":"MM Jin","year":"2018","unstructured":"Jin MM, Wang F, Qi D, Liu WW, Gu C, Mao CJ, Yang YP, Zhao Z et al (2018) A critical role of autophagy in regulating microglia polarization in neurodegeneration. Front Aging Neurosci 10:378","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"1921_CR91","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1021\/acschemneuro.7b00065","volume":"8","author":"T You","year":"2017","unstructured":"You T, Cheng Y, Zhong J, Bi B, Zeng B, Zheng W, Wang H, Xu J (2017) Roflupram, a phosphodiesterase 4 inhibitior, suppresses Inflammasome activation through autophagy in microglial cells. ACS Chem Neurosci 8(11):2381\u20132392","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"1921_CR92","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10571-018-0616-3","volume":"38","author":"G Chen","year":"2018","unstructured":"Chen G, Liu S, Pan R, Li G, Tang H, Jiang M, Xing Y, Jin F et al (2018) Curcumin attenuates gp120-induced microglial inflammation by inhibiting autophagy via the PI3K pathway. Cell Mol Neurobiol 38(8):1465\u20131477","journal-title":"Cell Mol Neurobiol"},{"key":"1921_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneuroim.2017.07.015","volume":"323","author":"H Shi","year":"2018","unstructured":"Shi H, Wang J, Wang J, Huang Z, Yang Z (2018) IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage. J Neuroimmunol 323:143\u2013151","journal-title":"J Neuroimmunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-01921-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:48:29Z","timestamp":1621496909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-01921-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-01921-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}